nach oben

Journal of Neural Transmission

Erschienen in:

01.06.2013 | Translational Neurosciences - Original Article

Synthesis, molecular modeling, and in vitro screening of monoamine oxidase inhibitory activities of some novel hydrazone derivatives

verfasst von: Umut Salgın-Gökşen, Nesrin Gökhan-Kelekçi, Samiye Yabanoglu-Çiftci, Kemal Yelekçi, Gülberk Uçar

Erschienen in: Journal of Neural Transmission | Ausgabe 6/2013

Einloggen, um Zugang zu erhalten

Abstract

Thirteen 2-[2-(5-methyl-2-benzoxazolinone-3-yl)acetyl]-3/4/5-substituted benzylidenehydrazine derivatives were synthesized by reacting 2-(5-methyl-2-benzoxazolinone-3-yl)acetylhydrazine and substituted benzaldehydes in neutral and acid/base catalyzed conditions, and a comparison was made in terms of their yields and reaction times. The structures of all compounds were confirmed by IR, ¹H NMR, ¹³C NMR, mass spectral data, and elemental analyses. All the compounds were investigated for their ability to selectively inhibit MAO isoforms by in vitro tests and were found to inhibit recombinant human MAO-B selectively and reversibly in a competitive manner. Among the compounds examined, compound 16 was found to be more selective than selegiline, a known MAO-B inhibitor, in respect to the K _i values experimentally found. Additionally, compounds 9 and 15 showed moderate MAO-B inhibitor activity. The interaction of compounds with MAO isoforms was investigated by molecular docking studies using recently published crystallographic models of MAO-A and MAO-B. The results obtained from the docking studies were found to be in good agreement with the experimental values.

Anderson MC, Hasan F, McCrodden JM, Tipton KF (1993) Monoamine oxidase inhibitors and the cheese effect. Neurochem Res 18:1145–1149PubMedCrossRef

Binda C, Wang J, Pisani L, Caccia C, Carotti A, Salvati P, Edmondson DE, Mattevi A (2007) Structures of human monoamine oxidase B complexes with selective noncovalent inhibitors: safinamide and coumarin analogs. J Med Chem 50:5848–5852PubMedCrossRef

Bradford MM (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72:248–254PubMedCrossRef

Chimenti F, Maccioni E, Secci D, Bolasco A, Chimenti P et al (2007) Selective inhibitory activity against MAO and molecular modeling studies of 2-thiazolylhydrazone derivatives. J Med Chem 50:707–712PubMedCrossRef

Chimenti F, Maccioni E, Secci D, Bolasco A, Chimenti P et al (2008) Synthesis, stereochemical identification, and selective inhibitory activity against human monoamine oxidase-B of 2-methylcyclohexylidene-(4-arylthiazol-2-yl)hydrazones. J Med Chem 51:4874–4880PubMedCrossRef

Chimenti F, Secci D, Bolasco A, Chimenti P, Arianna Granese A, Carradori S, D’Ascenzio M et al (2010a) Synthesis and selective inhibition of human monoamine oxidases of a large scaffold of (4,5-substituted-thiazol-2-yl)hydrazones. Med Chem Commun 1:61–72CrossRef

Chimenti F, Secci D, Bolasco A, Chimenti P, Arianna Granese A, Carradori S, Maccioni E et al (2010b) Synthesis, semipreparative HPLC separation, biological evaluation, and 3D-QSAR of hydrazothiazole derivatives as human monoamine oxidase B inhibitors. Bioorg Med Chem 18:5063–5070PubMedCrossRef

Chimenti F, Carradori S, Secci D, Bolasco A, Bizzarri B et al (2010c) Synthesis and inhibitory activity against human monoamine oxidase of N1-thiocarbamoyl-3,5-di(hetero)aryl-4,5-dihydro-(1H)-pyrazole derivatives. Eur J Med Chem 45:800–804PubMedCrossRef

Close WJ, Tiffany BD, Spielman MA (1949) The analgesic activity of some benzoxazolone derivatives. J Am Chem Soc 71:1265–1268PubMedCrossRef

Distinto S, Yanez M, Alcaro S, M. Cardia C, Gaspari M et al. (2012) Synthesis and biological assessment of novel 2-thiazolylhydrazones and computational analysis of their recognition by monoamine oxidase B. Eur J Med Chem 48:284–295

Elmer LW, Bertoni JM (2008) The increasing role of monoamine oxidase type B inhibitors in Parkinson’s disease therapy. Expert Opin Pharmacother 9:2759–2772PubMedCrossRef

Gökhan-Kelekçi N, Yabanoğlu S, Küpeli E, Salgın U, Özgen Ö et al (2007) A new therapeutic approach in alzheimer disease: some novel pyrazole derivatives as dual MAO-B inhibitors and antiinflammatory analgesics. Bioorg Med Chem 15:5775–5786PubMedCrossRef

Gökhan-Kelekçi N, Koyunoğlu S, Yabanoğlu S, Yelekçi K, Özgen Ö et al (2009a) New pyrazoline bearing 4(3H)-quinazolinone inhibitors of monoamine oxidase: synthesis, biological evaluation, and structural determinants of MAO-A and MAO-B selectivity. Bioorg Med Chem 17:675–689PubMedCrossRef

Gökhan-Kelekçi N, Şimşek ÖÖ, Ercan A, Yelekçi K, Şahin ZS et al (2009b) Synthesis and molecular modeling of some novel hexahydroindazole derivatives as potent monoamine oxidase inhibitors. Bioorg Med Chem 17:6761–6772PubMedCrossRef

Hassan GS, Kadry HH, Abou-Seri SM, Ali MM, El-Din Mahmoud AE (2011) Synthesis and in vitro cytotoxic activity of novel pyrazolo[3,4-d]pyrimidines and related pyrazole hydrazones toward breast adenocarcinoma MCF-7 cell line. Bioorg Med Chem 19:6808–6817

Himmelreich U, Tschwatschal F, Borsdorf R (1993) NMR-spektroskopische Untersuchungen an Derivaten des 2,4-Dichlorphenoxyessigsäurehydrazids. Monatsh Chem 124:1041–1051CrossRef

Huey R, Morris GM, Olson AJ, Goodsell DS (2007) A semi-empirical free energy force field with charge-based desolvation. J Comp Chem 28:1145–1152CrossRef

Iradyan MA, Aroyan RA, Stepanyan GM, Arsenyan FG, Garibdzhanyan BT (2008) Imidazole derivatives. XXX. Synthesis and antitumor activity of 4-amyloxy-3-nitroacetophenone 2-imidazolinyl-2-hydrazone and related compounds. Pharm Chem J 42:384–386CrossRef

Koçyiğit-Kaymakçıoğlu B, Oruç E, Unsalan S, Kandemirli F, Shvets N et al (2006) Synthesis and characterization of novel hydrazide-hydrazones and the study of their structure-antituberculosis activity. Eur J Med Chem 41:1253–1261CrossRef

Küçükgüzel SG, Mazi A, Sahin F, Öztürk S, Stables J (2003) Synthesis and biological activities of diflunisal hydrazide-/hydrazones. Eur J Med Chem 38:1005–1013PubMedCrossRef

Kulandasamy R, Adhikari AV, Stables JP (2009a) Synthesis and anticonvulsant activity of some new bishydrazones derived from 3,4-dipropyloxythiophene. Eur J Med Chem 44:3672–3679PubMedCrossRef

Kulandasamy R, Adhikari AV, Stables JP (2009b) A new class of anticonvulsants possessing 6 Hz activity: 3,4-dialkyloxy thiophene bishydrazones. Eur J Med Chem 44:4376–4384PubMedCrossRef

Kumar MJ, Nicholls DG, Andersen JK (2003) Oxidative a-ketoglutarate dehydrogenase inhibition via subtle elevations in monoamine oxidase B levels results in loss of spare respiratory capacity: implication for Parkinson’s disease. J Biol Chem 278:46432–46439PubMedCrossRef

MacKenzie EM, Fassihi A, Davood A, Chen O-H, Rauw G, Rauw G, Knaus EE, Baker GB (2008) N-Propynyl analogs of b-phenylethylidenehydrazines: synthesis and evaluation of effects on glycine, GABA, and monoamine oxidase. Bioorg Med Chem 16:8254–8263PubMedCrossRef

Milcent R, Akhnazarian A, Lensen N (1996) Synthesis of 1-(2-hydroxyphenyl)-2,4-imidazolidinedione derivatives through cyclic transformations of ethyl 2-oxo-3(2H)-benzoxazoleacetate derivatives. J Heterocycl Chem 33:1829–1833CrossRef

Mohareb RM, Fleita DH, Sakka OK (2011) Novel synthesis of hydrazide-hydrazone derivatives and their utilization in the synthesis of coumarin, pyridine, thiazole and thiophene derivatives with antitumor activity. Molecules 16:16–27CrossRef

Moldovan CM, Oniga O, Parvu A, Tiperciuc B, Verite P et al (2011) Synthesis and anti-inflammatory evaluation of some new acyl-hydrazones bearing 2-aryl-thiazole. Eur J Med Chem 46:526–534PubMedCrossRef

Morris GM, Huey R, Lindstrom W, Sanner MF, Belew RK, Goodsell DS, Olson AJ (2009) Autodock4 and AutoDockTools4: automated docking with selective receptor flexibility. J Comp Chem 16:2785–2791CrossRef

Oliveira KN, Costa P, Santin JR, Mazzambani L, Bürger C et al (2011) Synthesis and antidepressant-like activity evaluation of sulphonamides and sulphonyl-hydrazones. Bioorg Med Chem 19:4295–4306PubMedCrossRef

Palla G, Predieri G, Domiano P (1986) Conformational behaviour and E/Z isomerization of N-acyl and N-aroylhydrazones. Tetrahedron 42:3649–3654CrossRef

Rasras AJM, Al-Tel TH, Al-Aboudi AF, Al-Qawasmeh RA (2010) Synthesis and antimicrobial activity of cholic acid hydrazone analogues. Eur J Med Chem 45:2307–2313PubMedCrossRef

Rollas S, Küçükgüzel ŞG (2007) Biological activities of hydrazone derivatives. Molecules 12:1910–1939PubMedCrossRef

Salgın-Gökşen U, Gökhan-Kelekçi N, Göktaş Ö, Köysal Y, Kılıç E et al (2007) 1-Acylthiosemicarbazides, 1,2,4-triazole-5(4H)-thiones, 1,3,4-thiadiazoles and hydrazones containing 5-methyl-2-benzoxazolinones: synthesis, analgesic-anti-inflammatory and antimicrobial activities. Bioorg Med Chem 15:5738–5751PubMedCrossRef

Saura J, Luque JM, Cesura AM, Da Prada M, Chan-Palay V, Huber G, Loffler J, Richards JG (1994) Increased monoamine oxidase B activity in plaque associated astrocytes of Alzheimer brains revealed by quantitative enzyme radioautography. Neuroscience 62:15–30PubMedCrossRef

Son S-Y, Ma J, Kondou Y, Yoshimura M, Yamashita E, Tsukihara T (2008) Structure of human monoamine oxidase A at 2.2-Å resolution: the control of opening the entry for substrates/inhibitors. Proc Natl Acad Sci USA 105:5739–5744PubMedCrossRef

Sondhi SM, Dinodia M, Kumar A (2006) Synthesis, anti-inflammatory and analgesic activity evaluation of some amidine and hydrazone derivatives. Bioorg Med Chem 14:4657–4663PubMedCrossRef

Turan Zitouni G, Özdemir A, Kaplancıklı ZA, Revial G, Demirci F (2011) Synthesis and antimicrobial activity evaluation of new hydrazide derivatives. Turk J Pharm Sci 8:199–206

Vavrikova E, Polanc S, Kocevar M, Horvati K, Bösze S, Stolarikova J, Vavrova K, Vinsova J (2011) New fluorine-containing hydrazones active against MDR-tuberculosis. Eur J Med Chem 46:4937–4945PubMedCrossRef

Vicini P, Zani F, Cozzini P, Doytchinova I (2002) Hydrazones of 1,2-benzisothiazole hydrazides: synthesis, antimicrobial activity and QSAR investigations. Eur J Med Chem 37:553–564PubMedCrossRef

Wyrzykiewicz E, Blaszczyk A, Turowska-Tyrk I (2000) N-(E)-2-stilbenyloxymethylenecarbonyl substituted hydrazones of ortho, meta and para hydroxybenzaldehydes. Bull Pol Acad Sci Chem 4:213–229

Yáñez M, Fraiz N, Cano E, Orallo F (2006) Inhibitory effects of cis- and trans-resveratrol on noradrenaline and 5-hydroxytryptamine uptake and on monoamine oxidase activity. Biochem Biophys Res Commun 344:688–695PubMedCrossRef

Yelekçi K, Karahan Ö, Toprakçı M (2007) Docking of novel reversible monoamine oxidase-B inhibitors: efficient prediction of ligand binding sites and estimation of inhibitors thermodynamic properties. J Neural Transm 114:725–732PubMedCrossRef

Youdim MBH, Edmondson D, Tipton KF (2006) The therapeutic potential of monoamine oxidase inhibitors. Nat Rev Neurosci 7:295–309PubMedCrossRef

Titel: Synthesis, molecular modeling, and in vitro screening of monoamine oxidase inhibitory activities of some novel hydrazone derivatives
verfasst von: Umut Salgın-Gökşen
Nesrin Gökhan-Kelekçi
Samiye Yabanoglu-Çiftci
Kemal Yelekçi
Gülberk Uçar
Publikationsdatum: 01.06.2013
Verlag: Springer Vienna
Erschienen in: Journal of Neural Transmission / Ausgabe 6/2013
Print ISSN: 0300-9564
Elektronische ISSN: 1435-1463
DOI: https://doi.org/10.1007/s00702-013-0968-2

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Neurologie

Akuter Schwindel: Wann lohnt sich eine MRT?

28.04.2024 Schwindel Nachrichten

Akuter Schwindel stellt oft eine diagnostische Herausforderung dar. Wie nützlich dabei eine MRT ist, hat eine Studie aus Finnland untersucht. Immerhin einer von sechs Patienten wurde mit akutem ischämischem Schlaganfall diagnostiziert.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Frühe Alzheimertherapie lohnt sich

25.04.2024 AAN-Jahrestagung 2024 Nachrichten

Ist die Tau-Last noch gering, scheint der Vorteil von Lecanemab besonders groß zu sein. Und beginnen Erkrankte verzögert mit der Behandlung, erreichen sie nicht mehr die kognitive Leistung wie bei einem früheren Start. Darauf deuten neue Analysen der Phase-3-Studie Clarity AD.

Viel Bewegung in der Parkinsonforschung

25.04.2024 Parkinson-Krankheit Nachrichten

Neue arznei- und zellbasierte Ansätze, Frühdiagnose mit Bewegungssensoren, Rückenmarkstimulation gegen Gehblockaden – in der Parkinsonforschung tut sich einiges. Auf dem Deutschen Parkinsonkongress ging es auch viel um technische Innovationen.

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 6/2013

Characterization of diamine oxidase from human seminal plasma

Lack of association between VAP-1/SSAO activity and corneal neovascularization in a rabbit model

A comparison between radiometric and fluorimetric methods for measuring SSAO activity

Study on SSAO enzyme activity and anti-inflammatory effect of SSAO inhibitors in animal model of inflammation

Special Issue: 15th amine oxidase conference: re-examine the amines

Propargylamine-derived multitarget-directed ligands: fighting Alzheimer’s disease with monoamine oxidase inhibitors